Pacira Reports Preliminary Unaudited Fourth Quarter and Full-Year 2025 Revenues GlobeNewswire January 08, 2026 — Record-high EXPAREL sales driven by volume growth of 7 percent, marking strongest fourth quarter performance in three years– BRISBANE, Calif., Jan. 08, 2026 (GLOBE NEWSWIRE) — Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, […]
Vaxart to Participate in the Global BioInnovation Forum on January 13, 2026 GlobeNewswire January 08, 2026 SOUTH SAN FRANCISCO, Jan. 08, 2026 (GLOBE NEWSWIRE) — Vaxart, Inc. (OTCQX: VXRT) (“Vaxart or “the Company”), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, today announced that it
Week 52 COACH Trial Topline Results Confirm Consistent and Durable Treatment Benefits in Children with Achondroplasia (ACH) GlobeNewswire January 08, 2026 – Once-weekly TransCon(R) CNP and TransCon(R) hGH combination therapy showed durable growth without compromising safety or tolerability at 52 weeks – Annualized growth velocity (AGV) exceeded the 97th-percentile of average stature children – ACH
Senseonics Announces First Commercial Patients Using Eversense 365 Continuous Glucose Monitor (CGM) with twiist(TM) Automated Insulin Delivery (AID) System twiist(TM) becomes the first AID system compatible with Senseonics Eversense(R) 365 one-year CGM GlobeNewswire January 08, 2026 GERMANTOWN, Md., Jan. 08, 2026 (GLOBE NEWSWIRE) — Senseonics Holdings, Inc. (NASDAQ: SENS), a medical technology company focused on
Krystal Biotech Announces Positive Interim Clinical Update from KB407 Phase 1 CORAL-1 Study with Confirmation of Wild-Type CFTR Delivery to the Lungs of Patients with Cystic Fibrosis GlobeNewswire January 08, 2026 Confirmed wild-type CFTR delivery and expression in conducting airway cells of patients with class I mutations KB407 transduction confirmed in all six patients with
— Providing interim updates on ongoing in vivo CAR clinical programs — Highlighting non-human primate B cell depletion data with proprietary in vivo CAR-T CREATE Medicines, Inc. (“CREATE” or the “Company”), a clinical-stage biotechnology company pioneering in vivo CAR therapy, today announced it will present at the 44th Annual J.P. Morgan Healthcare Conference in San
Ziegler, a specialty investment bank, is pleased to announce the successful closing of Jennings Center for Older Adults’ $14,565,000 Series 2025 Bank Direct Placement Refunding Revenue Bonds (the Series 2025 Bonds) for the Senior Living Finance Practice. Jennings Center for Older Adults (Jennings) is a multi-site not-for-profit senior living organization located throughout northeast Ohio. Rooted
GIGABYTE, the world’s leading computer brand, showcases its AI TOP product line at CES 2026, highlighting that the rapid adoption of AI inferencing is accelerating the shift of AI from cloud to local. AI has become more accessible, responsive, and adaptable for everyday use, accomplishing the concept of “AI for everyone” in the AI era.
New ownership team launches Summit Point Leadership following ceremonial Veterans Day signing, marking a milestone in veteran-driven entrepreneurship An all-veteran ownership team, Summit Point Leadership LLC, which launched through the Jones Graduate School of Business at Rice University and its Entrepreneurship Through Acquisition (ETA) Lab, has acquired the business of LDR Leadership LLC, a nationwide
(NASDAQ:DFDV), BOCA RATON, FL, Jan. 08, 2026 (GLOBE NEWSWIRE) — DeFi Development Corp. (Nasdaq: DFDV) (the “Company”), the first US public company with a treasury strategy built to accumulate and compound Solana (“SOL”), today announced that Chief Strategy Officer Daniel Kang will be speaking at Needham's 28th Annual Growth Conference on Wednesday, January 14, 2026,